Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2018

View Archived Issues

Positive outcome from European decentralized procedure for Ferring's Testavan

Elthera generates preclinical proof-of-concept data with anti-L1CAM antibodies

EMA accepts type II variation application for Xtandi in non-metastatic CRPC

TissueGene changes name to Kolon TissueGene

Japan Tobacco and Rohto sign exclusive Japanese license agreement for JTE-052

eTheRNA completes low-dose cohort enrollment in phase Ib study of ECI-006 for melanoma

BMS-986166: a partial agonist of S1P1 with reduced pulmonary and cardiovascular toxicity

Bavarian Nordic partners with U.S. DoD to develop equine encephalitis virus vaccine

[225Ac]-PSMA radioligand therapy safe and effective in mCRPC patients

Valneva releases phase I interim data on Lyme vaccine candidate VLA-15

MicroRNA 520a is a potential prognostic biomarker of hepatocellular carcinoma

Novel HBV-replication inhibitors discovered at Gilead

Rutherrin shown to destroy human brain cancer stem cells

Lycera patents new Rho-associated protein kinase 1/2 inhibitors

Novel IDO-1 inhibitors presented by Bristol-Myers Squibb

Institute of Radiation Medicine presents novel compounds protecting against radiation

Sunshine Lake Pharma describes new influenza A virus H1N1 inhibitors

Mereo announces topline phase IIb results for BGS-649 to treat hypogonadotropic hypogonadism

Advaxis initiates phase I study of ADXS-NEO in solid tumors

Crinetics Pharmaceuticals' CRN-00808 shows promise in phase I acromegaly trial

Phase I data reported for intravesical VPM-1002BC in non-muscle invasive bladder cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...